Biomarkers of mitochondrial dysfunction and inflammaging in older adults and blood pressure variability

Selected Abstract – Spring Meeting 2023

Leonardo Bencivenga
Dipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli Federico II, Napoli, Italia and Gerontopole de Toulouse, Institut du Vieillissement, CHU de Toulouse, France
Mathilde Strumia
Gerontopole de Toulouse, Institut du Vieillissement, CHU de Toulouse, France and UMR INSERM 1295, Université Toulouse III, Toulouse, France
Yves Rolland
Gerontopole de Toulouse, Institut du Vieillissement, CHU de Toulouse, France and UMR INSERM 1295, Université Toulouse III, Toulouse, France
Sandrine Andrieu
Gerontopole de Toulouse, Institut du Vieillissement, CHU de Toulouse, France and UMR INSERM 1295, Université Toulouse III, Toulouse, France
Bruno Vellas
Gerontopole de Toulouse, Institut du Vieillissement, CHU de Toulouse, France and UMR INSERM 1295, Université Toulouse III, Toulouse, France
Philipe De Souto Barreto
Gerontopole de Toulouse, Institut du Vieillissement, CHU de Toulouse, France and UMR INSERM 1295, Université Toulouse III, Toulouse, France
Laure Rouch
Gerontopole de Toulouse, Institut du Vieillissement, CHU de Toulouse, France and UMR INSERM 1295, Université Toulouse III, Toulouse, France
for the MAPT/D. S. A. group | Bio

Abstract

Aim: Increased Blood Pressure (BP) Variability (BPV) may represent an alteration in BP physiological homeostatic patterns. Most physiopathological mechanisms underlying BPV are implicated in aging. Vascular aging is associated with chronic low-grade inflammation occurring in late life, known as "inflammaging", and the hallmark “mitochondrial dysfunction” associated to stress due to age-related disorders, which in turn might contribute to higher BPV and risk of cardiovascular disease. We aimed to determine whether plasma levels of the pleiotropic stress-related mitokine Growth/Differentiation Factor 15 (GDF-15) and two inflammatory biomarkers, Interleukin 6 (IL-6) and Tumor necrosis factor receptor 1 (TNFR-1), are associated with visit-to-visit BPV in a population of community-dwelling older adults.
Methods: The study population consisted of 1,096 participants [median age 75 (72-78) years; 699 females, 63.7%] selected among community-dwelling participants aged ≥70 years from the MAPT study. Plasma blood sample was collected 12 months after enrolment and BP was assessed up to seven times over a subsequent 4-year period. Systolic BPV (SBPV) and diastolic BPV (DBPV) were determined through several indicators including the coefficient of variation (CV%) and taking into account BP change over time, the order of measurements and formulas independent of mean BP levels.
Results: Higher values of GDF-15 were significantly associated with increased SBPV (all indicators) after adjustment for demographics, body mass index, MAPT randomization group, baseline systolic BP, antihypertensive drugs, diabetes mellitus, cardiovascular and non-cardiovascular comorbidities [adjusted 1-SD increase in GDF-15: β (SE)= 0.07 (0.04), p< 0.044, for CV%]. GDF-15 levels were not associated with DBPV. No significant associations were found between IL-6 and BPV, whereas TNFR1 was only partially related to DBPV.
Conclusions: Unlike inflammation biomarkers, higher GDF-15 levels were associated with greater SBPV. Our findings support the age-related process of mitochondrial dysfunction underlying BP instability, suggesting that BPV might be a potential marker of aging.

References

  1. Bencivenga, L., Strumia, M., Rolland, Y. et al. Biomarkers of mitochondrial dysfunction and inflammaging in older adults and blood pressure variability. GeroScience 45, 797–809 (2023). https://doi.org/10.1007/s11357-022-00697-y

Send mail to Author


Send Cancel

Custom technologies based on your needs

  • MongoDB
  • ElasticSearch
  • Redis
  • Solr
  • Memcached